Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Intestinal microbiome and fitness in kidney disease.

Meijers B, Evenepoel P, Anders HJ.

Nat Rev Nephrol. 2019 Jun 26. doi: 10.1038/s41581-019-0172-1. [Epub ahead of print] Review.

PMID:
31243394
2.

Persistent primary cytomegalovirus infection in a kidney transplant recipient: Multi-drug resistant and compartmentalized infection leading to graft loss.

Andrei G, Van Loon E, Lerut E, Victoor J, Meijers B, Bammens B, Sprangers B, Gillemot S, Fiten P, Opdenakker G, Lagrou K, Kuypers D, Snoeck R, Naesens M.

Antiviral Res. 2019 Aug;168:203-209. doi: 10.1016/j.antiviral.2019.06.004. Epub 2019 Jun 15.

PMID:
31212020
3.

Indoxyl Sulfate and p-Cresyl Sulfate Promote Vascular Calcification and Associate with Glucose Intolerance.

Opdebeeck B, Maudsley S, Azmi A, De Maré A, De Leger W, Meijers B, Verhulst A, Evenepoel P, D'Haese PC, Neven E.

J Am Soc Nephrol. 2019 May;30(5):751-766. doi: 10.1681/ASN.2018060609. Epub 2019 Apr 2.

PMID:
30940651
4.

Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients.

Evenepoel P, Claes K, Meijers B, Laurent MR, Bammens B, Naesens M, Sprangers B, Pottel H, Cavalier E, Kuypers D.

Kidney Int. 2019 Jun;95(6):1461-1470. doi: 10.1016/j.kint.2018.12.024. Epub 2019 Mar 4.

PMID:
30922664
5.

A distinct bone phenotype in ADPKD patients with end-stage renal disease.

Evenepoel P, Claes K, Cavalier E, Meijers B, Stenvinkel P, Behets G, Jankowska M, D'Haese P, Bammens B.

Kidney Int. 2019 Feb;95(2):412-419. doi: 10.1016/j.kint.2018.09.018.

PMID:
30665572
6.

Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal Disease.

Evenepoel P, Claes K, Meijers B, Laurent M, Bammens B, Naesens M, Sprangers B, Pottel H, Cavalier E, Kuypers D.

J Bone Miner Res. 2019 Feb;34(2):262-269. doi: 10.1002/jbmr.3608. Epub 2018 Nov 14.

PMID:
30427544
7.

Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol.

Evenepoel P, Claes K, Meijers B, Laurent MR, Bammens B, Naesens M, Sprangers B, Cavalier E, Kuypers D.

Nephrol Dial Transplant. 2018 Oct 17. doi: 10.1093/ndt/gfy306. [Epub ahead of print]

PMID:
30339234
8.

Haemodynamic or metabolic stimulation tests to reveal the renal functional response: requiem or revival?

De Moor B, Vanwalleghem JF, Swennen Q, Stas KJ, Meijers BKI.

Clin Kidney J. 2018 Oct;11(5):623-654. doi: 10.1093/ckj/sfy022. Epub 2018 Apr 13.

9.

Synthesis and post-functionalization of alternate-linked-meta-para-[2 n .1 n ]thiacyclophanes.

De Leger W, Adriaensen K, Robeyns K, Van Meervelt L, Thomas J, Meijers B, Smet M, Dehaen W.

Beilstein J Org Chem. 2018 Aug 22;14:2190-2197. doi: 10.3762/bjoc.14.192. eCollection 2018.

10.

Intestinal Barrier Function in Chronic Kidney Disease.

Meijers B, Farré R, Dejongh S, Vicario M, Evenepoel P.

Toxins (Basel). 2018 Jul 19;10(7). pii: E298. doi: 10.3390/toxins10070298. Review.

11.

Correction: The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.

Etinger A, Kumar SR, Ackley W, Soiefer L, Chun J, Singh P, Grossman E, Matalon A, Holzman RS, Meijers B, Lowenstein J.

PLoS One. 2018 Jul 16;13(7):e0200980. doi: 10.1371/journal.pone.0200980. eCollection 2018.

12.

Reliability of serum creatinine-based formulae estimating renal function in non-critically ill surgery patients: Focus on augmented renal clearance.

Declercq P, Gijsen M, Meijers B, Schetz M, Nijs S, D'Hoore A, Wauters J, Spriet I.

J Clin Pharm Ther. 2018 Oct;43(5):695-706. doi: 10.1111/jcpt.12695. Epub 2018 May 7.

PMID:
29733108
13.

Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease.

Meijers B, Jouret F, Evenepoel P.

Pharmacol Res. 2018 Jul;133:101-107. doi: 10.1016/j.phrs.2018.04.023. Epub 2018 Apr 30. Review.

14.

Nephrotic Syndrome: Genetics, Mechanism, and Therapies.

Shin JI, Kronbichler A, Oh J, Meijers B.

Biomed Res Int. 2018 Jan 28;2018:6215946. doi: 10.1155/2018/6215946. eCollection 2018. No abstract available.

15.

The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.

Etinger A, Kumar SR, Ackley W, Soiefer L, Chun J, Singh P, Grossman E, Matalon A, Holzman RS, Meijers B, Lowenstein J.

PLoS One. 2018 Feb 22;13(2):e0192770. doi: 10.1371/journal.pone.0192770. eCollection 2018. Erratum in: PLoS One. 2018 Jul 16;13(7):e0200980.

16.

p-cresol sulfate and indoxyl sulfate: some clouds are gathering in the uremic toxin sky.

Evenepoel P, Glorieux G, Meijers B.

Kidney Int. 2017 Dec;92(6):1323-1324. doi: 10.1016/j.kint.2017.06.029.

PMID:
29153138
17.

Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy.

Kronbichler A, Oh J, Meijers B, Mayer G, Shin JI.

Biomed Res Int. 2017;2017:1936372. doi: 10.1155/2017/1936372. Epub 2017 Aug 17. Review.

18.

Exploring binding characteristics and the related competition of different protein-bound uremic toxins.

Deltombe O, de Loor H, Glorieux G, Dhondt A, Van Biesen W, Meijers B, Eloot S.

Biochimie. 2017 Aug;139:20-26. doi: 10.1016/j.biochi.2017.05.010. Epub 2017 May 17.

PMID:
28528271
19.

Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.

Behets GJ, Viaene L, Meijers B, Blocki F, Brandenburg VM, Verhulst A, D'Haese PC, Evenepoel P.

PLoS One. 2017 May 11;12(5):e0176411. doi: 10.1371/journal.pone.0176411. eCollection 2017.

20.

A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.

Meijers B, Metalidis C, Vanhove T, Poesen R, Kuypers D, Evenepoel P.

Nephrol Dial Transplant. 2017 Apr 1;32(4):707-714. doi: 10.1093/ndt/gfw461.

PMID:
28407129
21.

The gut-kidney axis.

Evenepoel P, Poesen R, Meijers B.

Pediatr Nephrol. 2017 Nov;32(11):2005-2014. doi: 10.1007/s00467-016-3527-x. Epub 2016 Nov 15. Review.

PMID:
27848096
22.

The acute kidney injury e-alert and clinical care bundles: the road to success is always under construction.

Meijers B, De Moor B, Van Den Bosch B.

Nephrol Dial Transplant. 2016 Nov;31(11):1761-1763. Epub 2016 Jun 2. No abstract available.

PMID:
27257275
23.

HEMO Revisited: Why Kt/Vurea Only Tells Part of the Story.

Meijers B, Vanholder R.

J Am Soc Nephrol. 2016 Nov;27(11):3235-3237. Epub 2016 Jun 7. No abstract available.

24.

Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD.

Poesen R, Claes K, Evenepoel P, de Loor H, Augustijns P, Kuypers D, Meijers B.

J Am Soc Nephrol. 2016 Nov;27(11):3479-3487. Epub 2016 May 26.

25.

Effect of Treatment Duration and Frequency on Uremic Solute Kinetics, Clearances and Concentrations.

Leypoldt JK, Meijers BK.

Semin Dial. 2016 Nov;29(6):463-470. doi: 10.1111/sdi.12531. Epub 2016 Aug 31. Review.

PMID:
27578429
26.

A liquid chromatography - tandem mass spectrometry method to measure a selected panel of uremic retention solutes derived from endogenous and colonic microbial metabolism.

de Loor H, Poesen R, De Leger W, Dehaen W, Augustijns P, Evenepoel P, Meijers B.

Anal Chim Acta. 2016 Sep 14;936:149-56. doi: 10.1016/j.aca.2016.06.057. Epub 2016 Jul 2.

PMID:
27566350
27.

Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View.

Kronbichler A, Saleem MA, Meijers B, Shin JI.

J Immunol Res. 2016;2016:2068691. doi: 10.1155/2016/2068691. Epub 2016 Jul 18. Review.

28.

Updated Manufacturer and European Medicines Agency Recommendations on the Use of Mycophenolate Acid: Balancing the Risks for Male Allograft Recipients.

Kuypers DR, Van Mieghem T, Meijers B, Claes K.

Transplantation. 2016 Sep;100(9):e50-1. doi: 10.1097/TP.0000000000001342. No abstract available.

PMID:
27472093
29.

Focal Segmental Glomerulosclerosis: Genetics, Mechanism, and Therapies.

Kronbichler A, Oh J, Meijers B, Shin JI.

Biomed Res Int. 2016;2016:9643785. doi: 10.1155/2016/9643785. Epub 2016 Jun 26. No abstract available.

30.

Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism.

Evenepoel P, Claes K, Viaene L, Bammens B, Meijers B, Naesens M, Sprangers B, Kuypers D.

Transplantation. 2016 Oct;100(10):2188-93. doi: 10.1097/TP.0000000000001311.

PMID:
27379556
31.

FSGS: Diagnosis and Diagnostic Work-Up.

Sprangers B, Meijers B, Appel G.

Biomed Res Int. 2016;2016:4632768. doi: 10.1155/2016/4632768. Epub 2016 May 24. Review.

32.

Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease.

Poesen R, Meijers B, Evenepoel P.

JAMA Intern Med. 2016 Jun 1;176(6):867-8. doi: 10.1001/jamainternmed.2016.1854. No abstract available.

PMID:
27273496
33.

Two Cases of Heavy Chain MGUS.

Van Keer J, Meijers B, Delforge M, Verhoef G, Poesen K.

Case Rep Oncol Med. 2016;2016:8749153. doi: 10.1155/2016/8749153. Epub 2016 Apr 26.

34.

The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial.

Poesen R, Evenepoel P, de Loor H, Delcour JA, Courtin CM, Kuypers D, Augustijns P, Verbeke K, Meijers B.

PLoS One. 2016 Apr 21;11(4):e0153893. doi: 10.1371/journal.pone.0153893. eCollection 2016.

35.

Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.

Poesen R, Evenepoel P, de Loor H, Kuypers D, Augustijns P, Meijers B.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1136-44. doi: 10.2215/CJN.00160116. Epub 2016 Apr 15.

36.

Immunologic Changes Implicated in the Pathogenesis of Focal Segmental Glomerulosclerosis.

Kronbichler A, Leierer J, Oh J, Meijers B, Shin JI.

Biomed Res Int. 2016;2016:2150451. doi: 10.1155/2016/2150451. Epub 2016 Feb 17. Review.

37.

The influence of renal transplantation on retained microbial-human co-metabolites.

Poesen R, Evenepoel P, de Loor H, Bammens B, Claes K, Sprangers B, Naesens M, Kuypers D, Augustijns P, Meijers B.

Nephrol Dial Transplant. 2016 Oct;31(10):1721-1729. Epub 2016 Mar 8.

PMID:
26961998
38.

Phosphorus metabolism in peritoneal dialysis- and haemodialysis-treated patients.

Evenepoel P, Meijers BK, Bammens B, Viaene L, Claes K, Sprangers B, Naesens M, Hoekstra T, Schlieper G, Vanderschueren D, Kuypers D.

Nephrol Dial Transplant. 2016 Sep;31(9):1508-14. doi: 10.1093/ndt/gfv414. Epub 2016 Jan 31.

PMID:
26908778
39.

Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Ramezani A, Massy ZA, Meijers B, Evenepoel P, Vanholder R, Raj DS.

Am J Kidney Dis. 2016 Mar;67(3):483-98. doi: 10.1053/j.ajkd.2015.09.027. Epub 2015 Nov 15. Review.

40.

Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients.

Evenepoel P, Goffin E, Meijers B, Kanaan N, Bammens B, Coche E, Claes K, Jadoul M.

J Clin Endocrinol Metab. 2015 Dec;100(12):4669-76. doi: 10.1210/jc.2015-3056. Epub 2015 Oct 27.

PMID:
26505822
41.

The effect of anastomosis time on outcome in recipients of kidneys donated after brain death: a cohort study.

Heylen L, Naesens M, Jochmans I, Monbaliu D, Lerut E, Claes K, Heye S, Verhamme P, Coosemans W, Bammens B, Evenepoel P, Meijers B, Kuypers D, Sprangers B, Pirenne J.

Am J Transplant. 2015 Nov;15(11):2900-7. doi: 10.1111/ajt.13397.

42.

The Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites.

Poesen R, Mutsaers HA, Windey K, van den Broek PH, Verweij V, Augustijns P, Kuypers D, Jansen J, Evenepoel P, Verbeke K, Meijers B, Masereeuw R.

PLoS One. 2015 Oct 15;10(10):e0140820. doi: 10.1371/journal.pone.0140820. eCollection 2015.

43.

The Influence of CKD on Colonic Microbial Metabolism.

Poesen R, Windey K, Neven E, Kuypers D, De Preter V, Augustijns P, D'Haese P, Evenepoel P, Verbeke K, Meijers B.

J Am Soc Nephrol. 2016 May;27(5):1389-99. doi: 10.1681/ASN.2015030279. Epub 2015 Sep 23.

44.

Serum Concentrations of p-Cresyl Sulfate and Indoxyl Sulfate, but Not Inflammatory Markers, Increase in Incident Peritoneal Dialysis Patients in Parallel with Loss of Residual Renal Function.

Viaene L, Meijers BK, Vanrenterghem Y, Evenepoel P.

Perit Dial Int. 2015 Jul-Aug;35(4):492. doi: 10.3747/pdi.2015.00095. No abstract available.

45.

Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.

Poesen R, Ramezani A, Claes K, Augustijns P, Kuypers D, Barrows IR, Muralidharan J, Evenepoel P, Meijers B, Raj DS.

Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1525-33. doi: 10.2215/CJN.03100315. Epub 2015 Jul 7.

46.

Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study.

Naesens M, Lerut E, Emonds MP, Herelixka A, Evenepoel P, Claes K, Bammens B, Sprangers B, Meijers B, Jochmans I, Monbaliu D, Pirenne J, Kuypers DR.

J Am Soc Nephrol. 2016 Jan;27(1):281-92. doi: 10.1681/ASN.2015010062. Epub 2015 Jul 7.

47.

The metabolomics grail: promising although not yet holy.

Poesen R, Evenepoel P, Meijers B.

Kidney Int. 2015 Apr;87(4):864. doi: 10.1038/ki.2014.396. No abstract available.

PMID:
25826556
48.

Percutaneous rheolytic thrombectomy of thrombosed autogenous dialysis fistulas: technical results, clinical outcome, and factors influencing patency.

Maleux G, De Coster B, Laenen A, Vaninbroukx J, Meijers B, Claes K, Fourneau I, Heye S.

J Endovasc Ther. 2015 Feb;22(1):80-6. doi: 10.1177/1526602814566378.

PMID:
25775685
49.

From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.

Brandenburg VM, D'Haese P, Deck A, Mekahli D, Meijers B, Neven E, Evenepoel P.

Pediatr Nephrol. 2016 Feb;31(2):195-206. doi: 10.1007/s00467-015-3069-7. Epub 2015 Mar 4. Review.

PMID:
25735207
50.

Invasive aspergillosis after kidney transplant: case-control study.

Heylen L, Maertens J, Naesens M, Van Wijngaerden E, Lagrou K, Bammens B, Claes K, Evenepoel P, Meijers B, Kuypers D, Sprangers B.

Clin Infect Dis. 2015 May 15;60(10):1505-11. doi: 10.1093/cid/civ103. Epub 2015 Feb 13.

PMID:
25681376

Supplemental Content

Loading ...
Support Center